Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Squamous Cell

Explore clinical trials studying Neoplasms, Squamous Cell. Study availability and eligibility vary by location and protocol.

815 public trials 208 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Squamous Cell trial results

Active, Not Recruiting

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

NCT05966194

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

NCT04460937

Conditions
Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma

NCT05323253

Conditions
Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +8 more
Locations
  • Banner Health MD Anderson Phoenix Gilbert, Arizona, United States
  • Dignity Health Cancer Institute Phoenix, Arizona, United States
  • Alliance Dermatology Phoenix, Arizona, United States
  • UCLA Los Angeles, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

NCT04140500

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +32 more
Locations
  • Rigshospitalet København Ø, Denmark
  • Odense Universitetshospital, Onkologisk Afdeling R Odense C, Denmark
  • LLC Arensia Explorer Medicine Tbilisi, Georgia
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View all 25 locations
View Trial Details
Active, Not Recruiting

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma

NCT05784012

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
Locations
  • Institut Catalá d'Oncologia (ICO) BADALONA Badalona, Catalonia, Spain
  • Hospital Universitario Valle Hebron Barcelona, Catalonia, Spain
  • Hospital Clinic de Barcelona Barcelona, Catalonia, Spain
  • Institut Catalá d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Catalonia, Spain
View Trial Details

Related conditions